Ahead Therapeutics
PrivateLast Round
Grant
Jan 29, 2026
Est. Valuation
$14.12M
Total Funding Raised
$6.81M
Company Overview
Ahead Therapeutics is a biotechnology company that develops antigen-specific immune tolerance-generating therapies for autoimmune diseases using its proprietary MiMi-ToP nanotechnology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ahead Therapeutics Comparables
Compare Ahead Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anokion | 85% | |
| Topas Therapeutics | 83% | |
| Evoq Therapeutics | 83% |
Ahead Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 29, 2026 | ||||
| Debt | Dec 10, 2024 | ||||
| Crowdfunding | Apr 24, 2024 | ||||
| Seed | Jan 23, 2018 |
Key People
Founding team and executive leadership
Ahead Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JDRF | Grant |
| Capital Cell | Crowdfunding |
| Spanish Government (Ministry of Science) | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 47% MoM.
- Feb 1, 2026
Grew 18% QoQ, from 17 to 20 employees.
Ahead Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ahead Therapeutics's valuation, stock price, and market status.
Is Ahead Therapeutics a public or private company?
Ahead Therapeutics is a private company.
What is the current stock price of Ahead Therapeutics?
Ahead Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Ahead Therapeutics worth (valuation)?
Ahead Therapeutics's valuation is estimated at $14.1M based on funding round data.
Can I buy Ahead Therapeutics stock?
Ahead Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ahead Therapeutics's last funding round?
Ahead Therapeutics's most recent funding round was Grant on April 24, 2024.
Who are the main investors in Ahead Therapeutics?
Key investors in Ahead Therapeutics include JDRF, Spanish Government (Ministry of Science).
Will Ahead Therapeutics IPO soon?
No public IPO plans have been announced for Ahead Therapeutics.
How can I track Ahead Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ahead Therapeutics's secondary market activity and sign up for updates.